Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
North American Cerebral Oximeters North American Cerebral Oximeters
The North American cerebral oximeter device market is mainly driven by cardiac/vascular surgery, shoulder surgery, and single lung ventilation among other surgical procedures. The market was valued at $41.2 million in 2013, and is projected to reach $56.5 million by 2018, at a CAGR of 6.5%. Prominent players operating in the cerebral oximeter market are Covidien plc (Ireland), Nonin Medical, Inc. (U.S.), and CAS Medical Systems, Inc. (U.S.).
Upcoming
European Cerebral Oximeters European Cerebral Oximeters
The European cerebral oximeter device market is mainly driven by cardiac/vascular surgery, shoulder surgery, and single lung ventilation among other surgical procedures. The market was valued at $19.7 million in 2013, and is estimated to reach $27.3 million by 2018, at a CAGR of 6.7%. The prominent players in the cerebral oximeter market are Covidien plc (Ireland), Nonin Medical, Inc. (U.S.), and CAS Medical Systems, Inc. (U.S.).
Upcoming
North American Near Infrared Fluorescence North American Near Infrared Fluorescence
The North American Near-infrared fluorescence Imaging Devices Market, mainly driven by aging population, technological advancements, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “North American Near-infrared fluorescence imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies/products. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report North American Near-infrared fluorescence Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
North American Handheld Devices North American Handheld Devices
The North American Handheld Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “North American Handheld Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as by submarkets and by types. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report North American Handheld Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
Asian Handheld Devices Asian Handheld Devices
The Asian Handheld Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “Asian Handheld Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as by submarkets and by types. Geographically, the market is mainly segmented into China, Japan, India, and Rest of Asia-Pacific (APAC). The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in handheld device market and extensively covered in this report.
Upcoming
European Internal Beam Radiotherapy/Brachytherapy Market European Internal Beam Radiotherapy/Brachytherapy Market
The European Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $123.5 million in 2013 and expected to be $141.1 million by 2018, growing at a CAGR of 2.5%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA.
Upcoming
Asian Internal Beam Radiotherapy/Brachytherapy Market Asian Internal Beam Radiotherapy/Brachytherapy Market
The Asian Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $68.2 million in 2013 and expected to be $90.6 million by 2018, growing at a CAGR of 5.8%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA.
Upcoming
Asian Medical Automation Market Asian Medical Automation Market
The Asian Medical Automation Market was pegged at $6.6 billion in 2013 and expected to be $11.3 billion by 2018, growing at a CAGR of 11.3%. The report “Asian Medical Automation Market forecast, 2012-2018 “analyzes the market by 4 segments such as diagnostic and monitoring automation market, therapeutic automation market, lab and pharmacy automation market, and logistics and training automation market. The main companies operating in Medical automation market and extensively covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals and Konica Minolta Medical.
Upcoming
European Medical Automation Market European Medical Automation Market
The European Medical Automation market was $10.8 billion in 2013 and is expected to be $15.8 billion by 2018, at a CAGR of 7.8%. The report “European Medical Automation Market Forecast, 2012-2018”, analyzes the market by 4 segments such as diagnostic and monitoring, therapeutic, lab and pharmacy, and logistics and training. The key players of the market covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals, Konica Minolta Medical and others.
Upcoming
North American Medical Automation Market North American Medical Automation Market
The North American Medical Automation market was $23.3 billion in 2013 and is expected to be $35.9 billion by 2018, at a CAGR of 9%. The diagnostic and monitoring automation market is the largest segment of North American medical automation market. The report “North American Medical Automation Market Forecast, 2012-2018”, analyzes the market by 4 segments such as diagnostic and monitoring, therapeutic, lab and pharmacy, and logistics and training. The key players of the market covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals, Konica Minolta Medical and others.
Upcoming
European Proteomics European Proteomics
The European Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.28 billion in 2012 and is expected to be $ 7.35 billion by 2018, at a CAGR of 14.6%. The report “European Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Roche, etc.
Upcoming
European Non-Invasive Electrical Stimulators Market European Non-Invasive Electrical Stimulators Market
The report “The European Non-Invasive Electrical Stimulators Market devices market forecast 2012-2014” analyzes the market by technology into 2 segments such as Pulsed Electromagnetic Field Devices and Capacitive Coupling & Combined (electro) Magnetic Field Devices.Some of the key players in The European Non-Invasive Electrical Stimulators Market devices market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
Asian Automated External Defibrillators (AED) Asian Automated External Defibrillators (AED)
Asian market is expected to grow at the fastest rate.Recently North American Markets are showing a slow growth due to saturation of market.The Automated External Defibrillators Market can be segmented by Geographies, Product type, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in the report.
Upcoming
European Handheld Devices Market European Handheld Devices Market
The European Handheld Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “European Handheld Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as by submarkets and by types. Geographically, the market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of the Europe. The report European Handheld Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
Asian Insulin Delivery Devices Asian Insulin Delivery Devices
The Asian Insulin delivery Devices Market, mainly driven by increasing technological advancements, increasing prevalence to diabetes, increasing ageing population, increase in awareness of better diabetes management, and Product Innovation to increase acceptance. The report “Asian insulin delivery Devices Market forecast, 2008-2018 “analyzes the market of devices by products such as; insulin pens, insulin syringes, insulin pumps. Geographically, the market is mainly segmented into China, Japan, India, and Rest of the Asia-Pacific (APAC). The report Asian Insulin delivery Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
North American Tissue Diagnostics North American Tissue Diagnostics
  The North American Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, value was estimated to be $1,228.14 million in 2013 and is expected to be $1,684.24 million by 2018, at a CAGR of 6.52% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.).
Upcoming
European Insulin Delivery Devices European Insulin Delivery Devices
The European Insulin delivery Devices Market, mainly driven by increasing technological advancements, increasing prevalence to diabetes, increasing ageing population, increase in awareness of better diabetes management, and Product Innovation to increase acceptance. The report “European insulin delivery Devices Market forecast, 2008-2018 “analyzes the market of devices by products such as; insulin pens, insulin syringes, insulin pumps. Geographically, the market is mainly segmented into U.K., Germany France, Italy, Spain, and Rest of the Europe. The report European Insulin delivery Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
North American Insulin Delivery Devices North American Insulin Delivery Devices
The North American Insulin delivery Devices Market, mainly driven by increasing technological advancements, increasing prevalence to diabetes, increasing ageing population, increase in awareness of better diabetes management, and Product Innovation to increase acceptance. The report “North American insulin delivery Devices Market forecast, 2008-2018 “analyzes the market of devices by products such as; insulin pens, insulin syringes, insulin pumps. Geographically, the market is mainly segmented into U.S., Canada and Mexico. The report also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
North American Therapeutic Automation Market North American Therapeutic Automation Market
The North American Therapeutic Automation Market was valued at $7.4 billion in 2013 and is expected to reach $12.8 billion by 2018, at a CAGR of 11.7%. The report “North American Therapeutic Automation Market forecast, 2012-2018” analyzes the market by 2 segments such as surgical and non-surgical automation market. The main companies operating in therapeutic automation market and extensively covered in this report are Accuray, Intuitive Surgical, Zoll Medical Corporation, Boston Scientific, Asahi Kasei and others.
Upcoming
European Therapeutic Automation Market European Therapeutic Automation Market
The European Therapeutic Automation Market was valued at $3.1 billion in 2013 and is expected to reach $4.8 billion by 2018, at a CAGR of 8.7%. The report “European Therapeutic Automation Market forecast, 2012-2018” analyzes the market by 2 segments such as surgical and non-surgical automation market. The main companies operating in therapeutic automation market and extensively covered in this report are Accuray, Intuitive Surgical, Zoll Medical Corporation, Boston Scientific, Asahi Kasei and others.
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539